www.tesseratherapeutics.comHealthcareFounded: 2018Funding to Date: $558.91MM
Tessera Therapeutics is a life sciences company developing Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source.
